biotechnology esg compliance japan
5 Hidden Traps Corporate Governance Hurts Japan Biotech Fundraising
Only 12% of Japanese biotech firms adopted ESG disclosures following the new code - missed a wave of international funding and investor interest. Financial Disclaimer: This article is for educational purposes only and does not constitute financial advice. Consult a licensed financial advisor before making investment decisions. Corporate Governance 2024